Literature DB >> 8843978

Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment.

G W Clark1, A P Ireland, T R DeMeester.   

Abstract

Barrett's esophagus is a premalignant metaplastic change in the lining of the distal esophagus. It represents a peculiar form of healing which occurs in response to chronic gastroesophageal reflux disease. The condition should be considered in all patients undergoing endoscopy for symptoms of reflux disease and is confirmed when any biopsy shows the presence of specialized intestinal metaplasia irrespective of the macroscopic appearance of the distal esophagus. Endoscopic surveillance with multiple biopsy sampling of the esophageal mucosa is indicated for all medically fit patients with Barrett's esophagus. The diagnosis of dysplastic change within this abnormal mucosa requires histological examination of the biopsies by 2 independent but experienced pathologists. Identification of high-grade dysplasia heralds the development of invasive cancer and offers the physician an opportunity to intervene. Despite extensive endoscopic sampling of the esophageal mucosa the differentiation between high-grade dysplasia and invasive adenocarcinoma is unreliable. Esophagectomy remains the treatment of choice for patients with high-grade dysplasia since adenocarcinoma of the esophagus carries such a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843978     DOI: 10.1159/000171554

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  6 in total

Review 1.  Role of p53 assessment in management of Barrett's esophagus.

Authors:  A K Kubba; N A Poole; A Watson
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 2.  Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy.

Authors:  S R DeMeester; T R DeMeester
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

3.  NERD, GERD, and Barrett's esophagus: role of acid and non-acid reflux revisited with combined pH-impedance monitoring.

Authors:  Christian A Gutschow; Marc Bludau; Daniel Vallböhmer; Wolfgang Schröder; Elfriede Bollschweiler; Arnulf H Hölscher
Journal:  Dig Dis Sci       Date:  2008-04-26       Impact factor: 3.199

4.  Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.

Authors:  P Hinnen; F W de Rooij; E M Terlouw; A Edixhoven; H van Dekken; R van Hillegersberg; H W Tilanus; J H Wilson; P D Siersema
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

5.  Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.

Authors:  Fumiaki Sato; Zhe Jin; Karsten Schulmann; Jean Wang; Bruce D Greenwald; Tetsuo Ito; Takatsugu Kan; James P Hamilton; Jian Yang; Bogdan Paun; Stefan David; Alexandru Olaru; Yulan Cheng; Yuriko Mori; John M Abraham; Harris G Yfantis; Tsung-Teh Wu; Mary B Fredericksen; Kenneth K Wang; Marcia Canto; Yvonne Romero; Ziding Feng; Stephen J Meltzer
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

6.  CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer.

Authors:  F Cappello; F Rappa; R Anzalone; G La Rocca; G Zummo
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.